DK1417960T3 - Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf - Google Patents

Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1417960T3
DK1417960T3 DK02760617.7T DK02760617T DK1417960T3 DK 1417960 T3 DK1417960 T3 DK 1417960T3 DK 02760617 T DK02760617 T DK 02760617T DK 1417960 T3 DK1417960 T3 DK 1417960T3
Authority
DK
Denmark
Prior art keywords
water
micropellets
layer
sustained
making
Prior art date
Application number
DK02760617.7T
Other languages
English (en)
Inventor
Fumio Yoneda
Fumiya Hamano
Eisaku Kitano
Tetsuya Hosono
Original Assignee
Fujimoto Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Co Ltd filed Critical Fujimoto Co Ltd
Application granted granted Critical
Publication of DK1417960T3 publication Critical patent/DK1417960T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02760617.7T 2001-08-17 2002-08-12 Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf DK1417960T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001248426A JP4848101B2 (ja) 2001-08-17 2001-08-17 徐放性マイクロペレット
PCT/JP2002/008245 WO2003015758A1 (fr) 2001-08-17 2002-08-12 Micro-pastilles a liberation prolongee et procede permettant leur production

Publications (1)

Publication Number Publication Date
DK1417960T3 true DK1417960T3 (da) 2012-02-20

Family

ID=19077585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02760617.7T DK1417960T3 (da) 2001-08-17 2002-08-12 Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf

Country Status (9)

Country Link
US (2) US20040208930A1 (da)
EP (1) EP1417960B1 (da)
JP (1) JP4848101B2 (da)
AT (1) ATE531360T1 (da)
AU (1) AU2002327085B9 (da)
CA (1) CA2459472C (da)
DK (1) DK1417960T3 (da)
ES (1) ES2375624T3 (da)
WO (1) WO2003015758A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
US7598313B2 (en) * 2003-09-05 2009-10-06 University Of Massachusetts Amphiphilic polymer capsules and related methods of interfacial assembly
AU2004312059A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
WO2006038134A1 (en) * 2004-10-01 2006-04-13 Firmenich Sa Perfuming or flavouring microcapsules comprising an explosion suppressant
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
CN101166543B (zh) * 2005-04-28 2014-07-16 卫材R&D管理有限公司 含抗痴呆药物的组合物
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US8927025B2 (en) 2010-05-11 2015-01-06 Cima Labs Inc. Alcohol-resistant metoprolol-containing extended-release oral dosage forms
WO2023187225A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058890B2 (ja) * 1978-10-20 1985-12-23 東洋醸造株式会社 抗生物質細粒剤の製造法およびそれを用いる複粒剤
JPS583510A (ja) * 1981-06-29 1983-01-10 住友電気工業株式会社 海底ケ−ブル等の埋設機の積卸方法
JPS5835110A (ja) * 1981-08-28 1983-03-01 Tetsuo Kato 徐放性マイクロカプセル
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
GB2150434B (en) * 1983-12-01 1987-11-04 Alza Corp Constant rate release systems
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
JPH0832625B2 (ja) * 1987-01-29 1996-03-29 武田薬品工業株式会社 有核顆粒およびその製造法
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
FI900470A0 (fi) * 1989-01-31 1990-01-30 Int Pharma Agentur Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
IT1264020B (it) * 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
JPH09500645A (ja) * 1993-07-22 1997-01-21 ワーナー−ランバート・コンパニー 制御放出タクリン薬物送達システムおよびその製造方法
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
TW477702B (en) * 1997-10-23 2002-03-01 Dev Center Biotechnology Controlled release tacrine dosage form
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant

Also Published As

Publication number Publication date
JP4848101B2 (ja) 2011-12-28
WO2003015758A1 (fr) 2003-02-27
US8512744B2 (en) 2013-08-20
CA2459472C (en) 2010-12-14
EP1417960B1 (en) 2011-11-02
US20040208930A1 (en) 2004-10-21
AU2002327085B9 (en) 2008-08-14
EP1417960A4 (en) 2008-08-13
ES2375624T3 (es) 2012-03-02
US20090011034A1 (en) 2009-01-08
ATE531360T1 (de) 2011-11-15
CA2459472A1 (en) 2003-02-27
JP2003055199A (ja) 2003-02-26
EP1417960A1 (en) 2004-05-12
AU2002327085B2 (en) 2008-02-14
AU2002327085B8 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
CY1107695T1 (el) Μεθοδος παραγωγης επικαλυμμενων δισκιων με συγκαλυμμενη γευση και αμεση απελευθερωση του δραστικου παραγοντα
ATE281156T1 (de) Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
DE69917866D1 (de) Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
NZ512683A (en) Taste-masked pharmaceutical particles that are suitable for making chewable tablets
ATE366104T1 (de) Verfahren zur herstellung von in der mundhöhle rasch zerfallenden tabletten
FI853406A0 (fi) Kontrollerat frigjorda laekemedelsprodukter.
HRP960554A2 (en) Pharmaceutical formulations
YU31599A (sh) Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
ATE234077T1 (de) Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung
ATE258044T1 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
AU4693485A (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
ATE303141T1 (de) Ketoprofen mikrogranulat, verfahren zur herstellung desselben sowie pharmazeutische zusammensetzungen
ATE214598T1 (de) Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
DE60121874D1 (de) Verfahren zur Herstellung von porösen Copolyesteramidepulver und die so hergestellten Pulver
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
WO2003075898A3 (de) Filmüberzüge mit kontrollierter freisetzung und hoher stabilität
WO2003096874A3 (en) Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
DE69505247D1 (de) Hochkonzentriertes festes acifluorfenpulver und verfahren zur herstellung solches pulvers
EP1553453A3 (en) Water-soluble material, chemically amplified resist and pattern formation method using the same
DE60125226D1 (de) Verfahren zur herstellung von partikelförmigen polymerisaten
AU5068202A (en) Modified release pharmaceutical composition containing bupropion HCI as active substance